🟢 Edesa Biotech is trading 11.2% up today with no clear catalyst identified

Edesa Biotech is trading 11.2% up at $5.95 in after-hours trading with no clear catalyst identified to explain the move.

• No fresh company-specific news, earnings, FDA updates, or analyst calls dated July 27, 2026, were identified to account for the price action.
• The gain appears driven by light after-hours liquidity and opportunistic trading rather than a defined catalyst, extending a volatile recent stretch for the stock.
• The move follows a regular session close of $5.35 and occurs against a broadly mixed but mildly positive U.S. market backdrop.